Re-Purposing the Ordering of Routine Laboratory Tests in Hospitals in British Columbia

NCT06359587 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 700000

Last updated 2026-05-07

No results posted yet for this study

Summary

The goal of this stepped-wedge cluster randomized trial is to assess the impact of a laboratory test overuse intervention bundle on laboratory test utilization in 6 health authorities (16 hospitals) in British Columbia. The main question it aims to answer is if the intervention bundle, inclusive of healthcare provider and patient engagement tools, can be effectively implemented for hospitalized medical inpatients in 16 hospitals across BC and reduce laboratory test over-use. Researchers will compare hospital clusters that receive the intervention at different (sequential) time points to see if there are significant changes in the measured outcomes after the intervention.

Conditions

  • Hospital Acquired Condition

Interventions

BEHAVIORAL

Laboratory test overuse (LTO) Bundle

Key Components of the LTO Bundle: Educational materials, including an online module, clinical decision support tool, provision of lab utilization (Audit and Feedback) reports for healthcare providers. Patient engagement tools, such as videos and educational infographics. System level implementation tools adapted to the local context, including EMR-based tools and order set changes, etc.

Sponsors & Collaborators

  • Providence Health & Services

    collaborator OTHER
  • Vancouver Coastal Health

    collaborator OTHER_GOV
  • Fraser Health

    collaborator OTHER
  • Interior Health

    collaborator INDUSTRY
  • Northern Hospital, Australia

    collaborator OTHER
  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV
  • Island Health

    collaborator OTHER
  • University of British Columbia

    lead OTHER

Principal Investigators

  • Anshula Ambasta · University of British Columbia

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-06
Primary Completion
2026-11-16
Completion
2026-11-16

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06359587 on ClinicalTrials.gov